A phase 2 trial of avelumab in men with aggressive-variant or neuroendocrine prostate cancer
Landon C. Brown, Susan Halabi, Jason A. Somarelli, Michael Humeniuk, Yuan Wu, Taofik Oyekunle, Lauren E. Howard, Jiaoti Huang, Monika Anand, Catrin M. Davies, Prekshaben Patel, Janet Staats, Kent J. Weinhold, Michael R. Harrison, Tian Zhang, Daniel J. George, Andrew J. Armstrong
Topics & Concepts
MedicineClinical endpointProstate cancerInternal medicineGastroenterologyProgressive diseaseAvelumabOncologyUrologySurgeryCancerClinical trialImmunotherapyChemotherapyNivolumabProstate Cancer Treatment and ResearchRadiopharmaceutical Chemistry and ApplicationsBrain Metastases and Treatment